- Public Comps
- SI-BONE
SI-BONE Valuation Multiples
Discover revenue and EBITDA valuation multiples for SI-BONE and similar public comparables like Dynavox Group, MedCap, Anteris Technologies US, Synektik and more.
SI-BONE Overview
About SI-BONE
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Founded
2008
HQ

Employees
559
Website
Financials (LTM)
EV
$746M
Valuation Multiples
Start free trialSI-BONE Financials
SI-BONE reported last 12-month revenue of $220M and EBITDA of $11M.
In the same LTM period, SI-BONE generated $175M in gross profit, $11M in EBITDA, and had net loss of ($18M).
Revenue (LTM)
SI-BONE P&L
In the most recent fiscal year, SI-BONE reported revenue of $201M and EBITDA of ($11M).
SI-BONE is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of (5%), and net margin of (9%).
Financial data powered by Morningstar, Inc.
SI-BONE Stock Performance
SI-BONE has current market cap of $849M, and enterprise value of $746M.
Market Cap Evolution
SI-BONE's stock price is $18.95.
SI-BONE share price increased by 7.8% in the last 30 days, and by 13.7% in the last year.
SI-BONE has an EPS (earnings per share) of $-0.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $746M | $849M | -0.3% | 7.8% | 34.4% | 13.7% | $-0.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSI-BONE Valuation Multiples
SI-BONE trades at 3.4x EV/Revenue multiple, and 65.9x EV/EBITDA.
EV / Revenue (LTM)
SI-BONE Financial Valuation Multiples
As of August 14, 2026, SI-BONE has market cap of $849M and EV of $746M.
SI-BONE has a P/E ratio of (46.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SI-BONE Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SI-BONE Margins & Growth Rates
SI-BONE grew revenue by 16% but EBITDA decreased by 222% in the last fiscal year.
In the most recent fiscal year, SI-BONE reported gross margin of 80%, EBITDA margin of (5%), and net margin of (9%).
SI-BONE Margins
SI-BONE Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Operational KPIs
SI-BONE's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
SI-BONE's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SI-BONE's Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Competitors
SI-BONE competitors include Dynavox Group, MedCap, Anteris Technologies US, Synektik, Advanced Medical Solutions Group, InMode, Beta Bionics, CeriBell, SS Innovations and LifeTech Scientific.
Most SI-BONE public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.7x | 3.3x | 18.9x | 13.8x | |||
| 4.0x | 3.6x | 17.7x | 15.9x | |||
| 322.9x | 95.8x | (6.7x) | (5.6x) | |||
| 4.5x | 3.2x | 17.0x | 12.5x | |||
| 3.0x | 2.8x | 15.4x | 12.8x | |||
| 1.0x | 1.0x | 4.4x | 4.7x | |||
| 6.4x | 5.3x | (9.3x) | (9.7x) | |||
| 8.8x | 7.4x | (15.6x) | (13.3x) | |||
This data is available for Pro users. Sign up to see all SI-BONE competitors and their valuation data. Start Free Trial | ||||||
SI-BONE VC Funding History
Before going public, SI-BONE raised $80M in total equity funding, across 3 rounds.
SI-BONE Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SI-BONE
| Who are competitors of SI-BONE? | SI-BONE main competitors include Dynavox Group, MedCap, Anteris Technologies US, Synektik, Advanced Medical Solutions Group, InMode, Beta Bionics, CeriBell, SS Innovations, LifeTech Scientific. |
See public comps similar to SI-BONE
Lists including SI-BONE
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




